Pharmacy Benefit Managers and Vertical Relationships in Drug Supply: State of Current Research / Zarek C. Brot-Goldberg, Catherine Che, Benjamin R. Handel.
Material type:
- Analysis of Health Care Markets
- Analysis of Health Care Markets
- Health Insurance, Public and Private
- Health Insurance, Public and Private
- Market Structure, Firm Strategy, and Market Performance
- Market Structure, Firm Strategy, and Market Performance
- Vertical Restraints • Resale Price Maintenance • Quantity Discounts
- Vertical Restraints • Resale Price Maintenance • Quantity Discounts
- I11
- I13
- L1
- L42
- Hardcopy version available to institutional subscribers
Item type | Home library | Collection | Call number | Status | Date due | Barcode | Item holds | |
---|---|---|---|---|---|---|---|---|
Working Paper | Biblioteca Digital | Colección NBER | nber w29959 (Browse shelf(Opens below)) | Not For Loan |
April 2022.
Despite their importance to the supply of prescription drugs, there has been limited research on pharmacy benefit managers (PBMs) and their vertical relationships to insurers and drug manufacturers. This paper provides an overview of the current state of research on this topic, motivates why further research is needed, and discusses promising theoretical and empirical directions for that research.
Hardcopy version available to institutional subscribers
System requirements: Adobe [Acrobat] Reader required for PDF files.
Mode of access: World Wide Web.
Print version record
There are no comments on this title.